Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis

被引:50
|
作者
Wang, Jann-Yuan [1 ]
Lee, Li-Na [2 ]
Yu, Chong-Jen [1 ]
Chien, Yin-Ju [3 ]
Yang, Pan-Chyr [1 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Nursing, Yun Lin Branch, Douliou City, Taiwan
关键词
culture-positive; infectiousness; smear-positive; sputum smear conversion; tuberculosis; SPUTUM SMEAR; ANTITUBERCULOSIS DRUGS; MEDICAL-CENTER; CHEMOTHERAPY; HEPATITIS; INFECTION; CULTURE; BACILLI; ADULTS;
D O I
10.1111/j.1440-1843.2009.01598.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective: Persistent smear-positivity in patients with pulmonary tuberculosis has been shown to predict an unfavourable outcome. This study was conducted to identify the factors influencing time to sputum smear conversion. Methods: From July 2003 to June 2007, all patients with smear-positive and culture-confirmed pulmonary tuberculosis, who had attended a medical centre and a local teaching hospital, were identified. Factors that might have influenced time to smear conversion were investigated using time-to-event analysis. Results: Altogether 305 patients (mean age: 58.6 years) were studied. Diabetes mellitus was the most common underlying comorbidity. Eight patients (2.6%) had AIDS. After 2 months of treatment, 34 (11.1%) patients remained smear- and culture-positive. Cox proportional hazard regression analysis indicated that the presence of a cavity on CXR, smear grading and the first 2-month treatment regimen were independent factors influencing the time to sputum smear conversion. Among patients who had received isoniazid in the first 2 months of treatment, the time to sputum smear conversion in the 24 patients whose isolate showed isoniazid resistance was not different from that in the 236 patients whose isolate was isoniazid-susceptible (hazard ratio 1.061; 95% CI: 0.697-1.616). Conclusions: This analysis revealed that 11.1% of tuberculosis patients remained smear- positive after 2 months of treatment. Patients with cavitation, higher smear grading and those who had not used isoniazid, rifampicin, ethambutol and pyrazinamide continuously in the initial treatment phase had a longer time to sputum smear conversion.
引用
收藏
页码:1012 / 1019
页数:8
相关论文
共 50 条
  • [41] Efficiency of serial smear examinations in excluding sputum smear-positive tuberculosis
    Mabaera, B.
    Naranbat, N.
    Dhliwayo, P.
    Rieder, H. L.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2006, 10 (09) : 1030 - 1035
  • [42] Tuberculosis programme changes and treatment outcomes in patients with smear-positive pulmonary tuberculosis in Blantyre, Malawi
    Harries, AD
    Mbewe, LN
    Salaniponi, FML
    Nyangulu, DS
    Veen, J
    Ringdal, T
    Nunn, P
    [J]. LANCET, 1996, 347 (9004): : 807 - 809
  • [43] Factors influencing sputum smear conversion delay in tuberculosis
    Mejri, Islam
    Ben Saad, Soumaya
    Daghfous, Hahaoua
    Ben Khlifa, Mouna
    Tritar, Fatma
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [44] The incidence of recurrence of tuberculosis and its related factors in smear-positive pulmonary tuberculosis patients in Iran: A retrospective cohort study
    Moosazadeh, Mahmood
    Bahrampour, Abbas
    Nasehi, Mahshid
    Khanjani, Narges
    [J]. LUNG INDIA, 2015, 32 (06) : 557 - 560
  • [45] Prevalence and factors associated with sputum smear non-conversion after two months of tuberculosis treatment among smear-positive pulmonary tuberculosis patients in Rwanda: a cross-sectional study
    Gatete, Gaetan
    Njunwa, Kato J.
    Migambi, Patrick
    Ntaganira, Joseph
    Ndagijimana, Albert
    [J]. BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [46] SYMPTOMS OF PULMONARY TUBERCULOSIS IN CONSECUTIVE SMEAR-POSITIVE CASES TREATED IN ETHIOPIA
    TEKLU, B
    [J]. TUBERCLE AND LUNG DISEASE, 1993, 74 (02): : 126 - 128
  • [47] Prevalence and factors associated with sputum smear non-conversion after two months of tuberculosis treatment among smear-positive pulmonary tuberculosis patients in Rwanda: a cross-sectional study
    Gaetan Gatete
    Kato J Njunwa
    Patrick Migambi
    Joseph Ntaganira
    Albert Ndagijimana
    [J]. BMC Infectious Diseases, 23
  • [48] Pulmonary tuberculosis in Kweneng district, Botswana: delays in diagnosis in 212 smear-positive patients
    Steen, TW
    Mazonde, GN
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1998, 2 (08) : 627 - 634
  • [49] Delayed isolation of smear-positive pulmonary tuberculosis patients in a Japanese acute care hospital
    Sho Nishiguchi
    Shusaku Tomiyama
    Izumi Kitagawa
    Yasuharu Tokuda
    [J]. BMC Pulmonary Medicine, 18
  • [50] Adjunctive salvage therapy with inhaled aminoglycosides for patients with persistent smear-positive pulmonary tuberculosis
    Sacks, LV
    Pendle, S
    Orlovic, D
    Andre, M
    Popara, M
    Moore, G
    Thonell, L
    Hurwitz, S
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (01) : 44 - 49